Back
CI Balanced Growth Asset Allc ETF Comm Vs. Dyne Therapeutics Industry Stock Comparison
Buy
90
CBGR.TO
CI Balanced Growth Asset Allc ETF Comm
Last Price:
23.81
Seasonality Move:
4.97%
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
90
CI Balanced Growth Asset Allc ETF Comm (CBGR.TO)
is a Buy
Is CI Balanced Growth Asset Allc ETF Comm a Buy, Sell or Hold?
- The current CI Balanced Growth Asset Allc ETF Comm [CBGR.TO] share price is $23.81. The Score for CBGR.TO is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
- CBGR.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CBGR.TO Stock Price Chart
What is CI Balanced Growth Asset Allc ETF Comm's stock price today?
-
The CI Balanced Growth Asset Allc ETF Comm share price today is $23.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CBGR.TO is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $34.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CBGR.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 77.29 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.22 - 23.6) | Buy |
| Bollinger Bands (100): | (22.34 - 23.32) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 60.64 | Buy |
| Chaikin Money Flow: | 1192325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.99 - 33.51) | Buy |
| Bollinger Bands (100): | (31.49 - 42.59) | Sell |
CBGR.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.47 | Buy |
| 20-day SMA: | 23.45 | Buy |
| 50-day SMA: | 23.22 | Buy |
| 200-day SMA: | 22.1 | Buy |
| 8-day EMA: | 23.57 | Buy |
| 20-day EMA: | 23.44 | Buy |
| 50-day EMA: | 23.21 | Buy |
| 200-day EMA: | 22.2 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.58 | Buy |
| 20-day SMA: | 30.81 | Buy |
| 50-day SMA: | 32.62 | Buy |
| 200-day SMA: | 32.06 | Buy |
| 8-day EMA: | 30.24 | Buy |
| 20-day EMA: | 30.74 | Buy |
| 50-day EMA: | 32.95 | Buy |
| 200-day EMA: | 30.83 | Buy |
CI Balanced Growth Asset Allc ETF Comm Earnings Growth & CBGR.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
CI Balanced Growth Asset Allc ETF Comm Technical Analysis
| Oct 30 | Oct 31 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||